Golrang Pharmaceutical Investment Co.

Staff
0 +
Subsidiaries
0
API
0 +
Final Drug Product
0 +
Medical Supplement
0 +

Health is our Heritage

Golrang Pharmaceutical Activities

Faran Shimi Company,
Abian Pharmed Company,
Varian Pharmed Company.

Soroush Mana Pharmed Company,
Hasti Arya Shimi (Hita pharma)Company,
Faran SHimi Company

Faran Shimi Company,
Abian Pharmed Company,
Arian Salamat Sina Company,
Pharmed Salamat Sina Company,

Vanda Pharmed 
Abian Darou Company,
Faran Pharmed Company,
Smart Nutrition Taghzie Asan Company

Salamat Pakhsh Hasti Company

Faran Shimi Company,
Varian Pharmed Company.

Soroush Mana Pharmed Company

Aban Darman Behbood

Tivan Tamin Pars

Pharmaceutical Holding

Golrang Pharmaceutical Investment Company was established in 2010 by Golrang Industrial Group in the Islamic Republic of Iran and entered into the important and fundamental field of the pharmaceutical industry. With the help of its knowledge-based companies, experienced managers and the round-the-clock efforts of specialized staff, Golrang Pharmaceutical Investment Company has paved the route of progress in the field of production and supply of pharmaceutical products in such a way that nowadays, not only it possesses the ability to produce pharmaceutical products from raw material(API) to the final product, but also exports a significant amount of its products to other countries. Currently, 12 companies with 260 products are active in the fields of pharmaceuticals, raw materials, final products, pharmaceutical, herbal and food supplements.

Vision

Values

Mission

December 17, 2025

Participation of Golrang Drug and Health Innovation Center in Tehran University of Medical Sciences Research and Technology Ecosystem Program

The Golrang Drug and Health Innovation Center participated in the “Research and Technology Ecosystem of Tehran University of Medical...
December 8, 2025

Launch of “OctaHeal Alpha‑Lipoic Acid” Supplement for Diabetic Patients by Faran Shimi

Faran Shimi Knowledge-Based Company, a subsidiary of Golrang Pharmaceutical Investment Group, has announced the official launch of OctaHeal Alpha‑Lipoic...
December 3, 2025

Participation of Golrang Pharmaceutical Group in the Afghan Health Exhibition in Kabul

Golrang Pharmaceutical Investment Group participated in the Afghan Health Exhibition with the aim of exporting pharmaceutical products and dietary...
November 30, 2025

Evaluation of 9 Innovative Projects in the Pharmaceutical and Health Sector at Golrang Pharmaceutical Investment Group Innovation Center for Investment and Partnership

The second Golrang Pharmaceutical and Health Innovation Event was held on December 29, 2025 (8 Azar 1404), with the...
November 23, 2025

Golrang Pharmaceutical Group and TPO Africa Office Discuss Expanding Pharma Exports to Africa

A joint meeting was held between the executives of Golrang Pharmaceutical Investment Group and the Director General and Senior...
November 19, 2025

Launch of Macitentan in Iran’s Pharmaceutical Market by Faran Shimi

Faran Shimi, a subsidiary of Golrang Pharmaceutical Group, has announced the official launch of the drug Macitentan in the...

All rights reserved for Golrang Pharmaceutical Investment Company.